- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/10 - Peptides having 12 to 20 amino acids
Patent holdings for IPC class A61K 38/10
Total number of patents in this class: 4025
10-year publication summary
279
|
321
|
286
|
339
|
324
|
395
|
284
|
269
|
211
|
50
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
83 |
GemVax & Kael Co., Ltd. | 84 |
39 |
Ironwood Pharmaceuticals, Inc. | 165 |
38 |
Biokine Therapeutics Ltd. | 53 |
34 |
Bausch Health Ireland Limited | 751 |
33 |
Biolinerx Ltd. | 65 |
31 |
NoNO Inc. | 88 |
30 |
Nymox Corporation | 42 |
30 |
The Johns Hopkins University | 5377 |
28 |
The Trustees of the University of Pennsylvania | 4122 |
26 |
Immatics Biotechnologies GmbH | 1144 |
23 |
Mondobiotech Laboratories AG | 311 |
23 |
The Board of Trustees of the University of Illinois | 2623 |
22 |
Centre National de La Recherche Scientifique | 9632 |
21 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
21 |
Bristol-myers Squibb Company | 5080 |
20 |
Apellis Pharmaceuticals, Inc. | 109 |
20 |
Kim, Sang JAE | 34 |
20 |
Agency for Science, Technology and Research | 3512 |
19 |
Protagonist Therapeutics, Inc. | 124 |
19 |
Other owners | 3445 |